Community Home

Log in or Join to View Discussions

Latest Discussion Posts

  • Registration Link: https://diaglobal.zoom.us/webinar/register/WN_0Ad0atujQ3qToM_Nh6uJsw Title: Clinically Meaningful: How is it Different From Statistically Significant? Date and Time: 04 November 2020 - 11:00am - 12:30pm ET The Statistics and Data ...

  • Dear All, Just a reminder that poster abstracts for the virtual Global Clinical Trial Disclosure & Data Transparency Conference on November 16 th – 18 th are due October 15 th ( https://www.diaglobal.org/abstract/meeting-details?productID=9289747&productcode=20119CFP ...

  • The DIA's Study Endpoint Community is hosting an educational presentation on September 30th.  Please plan to join us. Title:   What is the effect of a new treatment on HRQoL – how can we clarify what we plan to analyse in randomised clinical trials? ...

  • The DIA's Study Endpoint Community is hosting an educational presentation on September 30th. Title:  What is the effect of a new treatment on HRQoL – how can we clarify what we plan to analyse in randomised clinical trials? Understanding estimands ...

  • Dear All, The Statistics and Data Science Community will be hosting a Digital Health Technology Webinar on 9/16/2020 11:00-12:30 ET. Registration Link:  https://diaglobal.zoom.us/webinar/register/WN_HfpGW89ZQCu7ZwiO-sc8Mw The "Statistical, Regulatory, ...

  • Leaders from the DIA Study Endpoints, Clinical Research, and Statistics & Data Science Communities are organizing a Working Group with a goal of tackling the important topic clinically meaningful change – moving the discussion beyond MCID/MID and homogenous ...

    1 person likes this.
  • Title: THE POWER OF AI IN BIOLOGICS DRUG DESIGN, PRE-CLINICAL AND CLINICAL DEVELOPMENT Date: 21 July 2020, 10:00am - 11:30am EST (14:00 - 15:30 GMT) Registration Link:   https://diaglobal.zoom.us/webinar/register/WN_VUvDHq7fRzO_057PMaZRr4 Brought ...

  • Please join the DIA's Study Endpoints Community's upcoming Webinar "Endpoints in Oncology – opportunities and challenges." The endpoint landscape for drug development in Oncology is changing. These changes offer significant opportunities to researchers ...

  • ​ Please plan to join the next educational presentation hosted by the DIA's Study Endpoint Community on April 29th at 11am ET. The endpoint landscape for drug development in Oncology is changing. These changes offer significant opportunities to ...

  • The DIA's Study Endpoints Community is hosting its last educational presentation of 2019 on December 11th at 11am ET Title:  Interviews with clinical trial patients: Scientific and practical considerations . Presenters:  Jennifer Devlen, PhD, Principal, ...

Upcoming Events